Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8097
|
pubmed:dateCreated |
1979-1-24
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
4
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
994-5
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:82019-Acetylation,
pubmed-meshheading:82019-Clinical Trials as Topic,
pubmed-meshheading:82019-Dose-Response Relationship, Drug,
pubmed-meshheading:82019-Double-Blind Method,
pubmed-meshheading:82019-Humans,
pubmed-meshheading:82019-Neurotic Disorders,
pubmed-meshheading:82019-Phenelzine,
pubmed-meshheading:82019-Time Factors
|
pubmed:year |
1978
|
pubmed:articleTitle |
Acetylator status and response to phenelzine.
|
pubmed:publicationType |
Letter,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial
|